Tuesday, February 18, 2014 | 8:30 AM - 4:30 PM
Speakers: John DiPersio (Washington University School of Medicine), William R. Drobyski (Medical College of Wisconsin), James Ferrara (University of Michigan), David L. Porter, MD, University of Pennsylvania Medical Center, Robert J. Soiffer (Dana-Farber Cancer Institute), Megan Sykes (Columbia University), Marcel RM van den Brink (Memorial Sloan Kettering Cancer Center)
Mechanisms that cause graft-versus-host disease (GvHD), a major cause of mortality after stem cell transplants, must be inhibited while preserving the graft-versus-tumor (GvT) response. Explore recent advances in separating GvHD from GvT effects.
Friday, April 25, 2014 | 8:00 AM - 5:30 PM
Keynote Speakers: Jane M. Carlton (New York University), Rick M. Fairhurst (National Institute of Allergy and Infectious Disease, NIH), Terrie E. Taylor (Michigan State University)
Speakers: Myles Akabas (Albert Einstein College of Medicine), Purnima Bhanot (UMDNJ - New Jersey Medical School), Liwang Cui (Pennsylvania State University), Mahalia S. Desruisseaux (Albert Einstein College of Medicine), Miriam K. Laufer (University of Maryland School of Medicine), Laura Kirkman (Weill Cornell Medical College), Marcus Lee (Columbia University), Alexander Ploss (Princeton University), Photini Sinnis (Johns Hopkins University)
Despite a 25% reduction in global malaria mortality since 2000, around half the world's population is at risk. Join us on World Malaria Day to examine breakthroughs in pathophysiology, pre-erythrocytic and liver stage biology, and drug development.
Monday, December 2, 2013 | 7:00 PM - 8:30 PM
Speakers: Lawrence Brandt (Albert Einstein College of Medicine), Martin Blaser (New York University Medical Center), Maria Gloria Dominguez-Bello (New York University)
Join us to learn about our basic microbial ecology; how our gut bacteria are linked to diabetes and obesity; how newborns are first colonized by bacteria; and how treatments are changing people's lives one single-celled organism at a time.
Thursday, November 14, 2013 | 12:00 PM - 4:00 PM
Keynote Speaker: Nancy J. Cox (Centers for Disease Control and Prevention)
Speakers: Kathy Coelingh (MedImmune), Manon M. J. Cox (Protein Sciences), Ruben Donis (Centers for Disease Control and Prevention), Philip R. Dormitzer (Novartis Vaccines and Diagnostics), David P. Greenberg (Sanofi Pasteur US)
Evolution of the influenza virus and emergence of new viruses from animals pose a continuing challenge. H7N9, H1N1pdm and H5N1 are all sources of ongoing concern. Explore quadrivalent vaccines, efforts to boost efficacy, and recent FDA approvals.
Monday, October 28, 2013 | 8:00 AM - 5:00 PM
Speakers: Richard L. Edelson (Yale School of Medicine), Edgar G. Engleman (Stanford University School of Medicine), Thomas Felzmann (Activartis Biotech GmbH, Austria), Lana E. Kandalaft (University of Pennsylvania), Matthew Lehman (Prima Biomed, Australia), Gregory Lizee (MD Anderson Cancer Center), Charles A. Nicolette (Argos Therapeutics Inc.), Sarah J. Schlesinger (The Rockefeller University), Adam Steinman, Kris Thielemans (Vrije Universiteit Brussel, Belgium), James B. Trager (Dendreon Corporation), John S. Yu (Cedars-Sinai Medical Center and Immunocellular Therapeutics, Ltd.)
Dendritic cells offer promise in the development of cancer vaccines. Despite recent approval of Provenge, this therapeutic approach has not been fully realized. This symposium highlights recent clinical trial results and remaining challenges.
Friday, October 4, 2013 | 8:00 AM - 5:00 PM
Speakers: David Artis (University of Pennsylvania), Stephen M. Collins (McMaster University), Michael A. Fischbach (University of California, San Francisco), Dirk Gevers (The Broad Institute of MIT and Harvard), Jeremy K. Nicholson (Imperial College London), Lita M. Proctor (National Human Genome Research Institute, NIH), Nilufer Seth (Pfizer Global Research and Development)
Symbioses between humans and our gut microbiome influence human biology including nutrition, immune function, and brain development. We review how symbiotic relationships impact drug metabolism and development, and a variety of disease states. This symposium features a poster session.
Organizers: Mercedes Beyna (Pfizer), Robert Martone (Covance Biomarker Center of Excellence), Nilufer Seth (Pfizer), Richard Snyder (Covance Biomarker Center of Excellence), and Jennifer Henry (The New York Academy of Sciences)
This eBriefing looks at how symbioses between humans and the gut microbiome impact drug metabolism, development, and a variety of disease states.
Keynote Speakers: Alfred W. Sandrock Jr. (Biogen Idec) and Declan R. Walsh (Deferno Trust)
This eBriefing reviews new basic science and clinical findings on the pathogenesis, mitigation, cure, and risk stratification of PML.
Featured Speaker: David Julius (University of California, San Francisco)
This eBriefing features David Julius, the recipient of the 2013 Dr. Paul Janssen Award for Biomedical Research for his role in discovering a mechanism for nociception and thermosensation. Recent research on pain is also described.
Scientific Organizing Committee Chairman: Ivo Mueller (ISGlobal; CRESIB; Walter and Eliza Hall Institute)
Keynote Speaker: Robert D. Newman (World Health Organization)
This eBriefing explores Plasmodium vivax biology and genomics; drug resistance and discovery; and recent clinical trials and in-field efforts in P. vivax malaria prevention, treatment, control, and elimination.
Delve into the world of prebiotic and probiotic science. We talk to three people in the field and learn why keeping the good microbes in our bodies happy means a lot for health.
March 2, 2010
Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.